Cargando…
Targeting MCL1 to induce mitophagy is a potential therapeutic strategy for Alzheimer disease
Mitochondrial dysfunction is associated with the occurrence of a variety of neurodegenerative diseases, especially Alzheimer disease (AD). As a mitochondrial quality control process, mitophagy is greatly inhibited in AD; increasing evidence shows that the induction of mitophagy is an effective thera...
Autores principales: | Cen, Xufeng, Xu, Xiaoyan, Xia, Hongguang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8032245/ https://www.ncbi.nlm.nih.gov/pubmed/33342330 http://dx.doi.org/10.1080/15548627.2020.1860542 |
Ejemplares similares
-
LYECs: lysosome-enhancing compounds as potential therapeutic approaches for Alzheimer disease
por: Yin, Limin, et al.
Publicado: (2022) -
Lipid droplets promote efficient mitophagy
por: Long, Maeve, et al.
Publicado: (2022) -
SREBF1 links lipogenesis to mitophagy and sporadic Parkinson disease
por: Ivatt, Rachael M, et al.
Publicado: (2014) -
Methylmalonyl acidemia: from mitochondrial metabolism to defective mitophagy and disease
por: Luciani, Alessandro, et al.
Publicado: (2020) -
GAK and PRKCD kinases regulate basal mitophagy
por: Munson, Michael J., et al.
Publicado: (2022)